Altimmune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.

About ALT

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.

CEO

Vipin K. Garg

CEOVipin K. Garg

Employees

Employees59

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1997

Founded1997

Employees

Employees59

ALT Key Statistics

Market cap

331.32M

Market cap331.32M

Price-Earnings ratio

-3.23

Price-Earnings ratio-3.23

Dividend yield

—

Dividend yield—

Average volume

4.68M

Average volume4.68M

High today

$4.25

High today$4.25

Low today

$4.05

Low today$4.05

Open price

$4.14

Open price$4.14

Volume

3.50M

Volume3.50M

52 Week high

$11.16

52 Week high$11.16

52 Week low

$2.90

52 Week low$2.90

Analyst ratings

80%

of 10 ratings

Buy

80%

Hold

10%

Sell

10%

People also own

Based on the portfolios of people who own ALT. This list is generated using Robinhood data, and it’s not a recommendation.